董 芬, 张 彪, 单广良. Distribution and risk factors of thyroid cancer in China[J]. China Oncology, 2016, 26(1): 47-52. DOI: 10.3969/j.issn.1007-3969.2016.01.008.
Distribution and risk factors of thyroid cancer in China
Incidence of thyroid cancer has continuously increased in the last three decades globally. A similar trend of thyroid cancer incidence appeared in China. New cases and deaths of thyroid cancer in China accounted for 15.6% and 13.8% of the global new cases and deaths in 2012. The incidence in East China was the highest while that in Middle China was the lowest. Thyroid cancer was more common in urban areas than in rural counterparts. The incidence was substantially higher in female patients than male. Thyroid cancer occurred most commonly in middle age. Radiation exposure
iodine sufficiency or deficiency
sex hormone and genetic mutations were risk factors for thyroid cancer. To prevent it
potassium iodide should be taken to prevent radiation fallout in nuclear accidents
unnecessary exposure to radiation from medical imaging is reduced
iodine surveillance system is improved and appropriate standards for iodized salt are established.
Research progress in epidemiology and risk factors of thyroid cancer
Clinical analysis of tumor related venous thromboembolism: 196 cases
Interpretation of the 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer: advances in surgical treatment of differentiated thyroid cancer
Expert consensus on BRCA1/2 gene testing and clinical application in Chinese breast cancer patients (2025 edition)
Analysis of etiological characteristics, risk factors and inflammatory factors in patients with postoperative infection following modified radical mastectomy
Related Author
Zhiyue ZHANG
Huijing HE
Guangliang SHAN
Yansong LIN
申丽华
张忠伟
朱 彪
Qian SHI
Related Institution
Department of Epidemiology and Statistics, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences/Peking Union Medical College
School of Health Humanities, Peking University
Department of Nuclear Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, State Key Laboratory of Complex Severe and Rare Diseases, Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine
复旦大学附属肿瘤医院麻醉科重症监护室,复旦大学上海医学院肿瘤学系
Department of Otolaryngology-Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University